MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$30,250K
EPS
-$0.66
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
21,864
18,963
13,121*
16,044
General and administrative
10,606
10,636
7,293*
7,761
Total operating expenses
32,470
29,599
20,414
23,805
Loss from operations
-32,470
-29,599
-20,414*
-23,805
Interest income
2,587
2,820
2,611*
3,456
Other income
-
0
56*
71
Other income (expense), net
-3
-
-
-
Total other income
2,584
2,820
2,667*
3,527
Net loss
-29,886
-26,779
-17,748*
-20,278
Unrealized gain on marketable securities
-364
-624
-6
237
Total other comprehensive gain
-364
-624
-6*
237
Comprehensive loss
-30,250
-27,403
-17,755
-20,041
Basic EPS
-0.66
-0.6
-0.563
-0.46
Diluted EPS
-0.66
-0.6
-0.563
-0.46
Basic Average Shares
45,148,971
44,921,984
31,514,439
44,255,053
Diluted Average Shares
45,148,971
44,921,984
31,514,439
44,255,053
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$30,250K
(-66.34%↓ Y/Y)
Interest income
$2,587K
(-29.45%↓ Y/Y)
Net loss
-$29,886K
(-65.41%↓ Y/Y)
Total other
comprehensive gain
-$364K
(-208.47%↓ Y/Y)
Total other income
$2,584K
(-32.67%↓ Y/Y)
Other income
(expense), net
-$3K
Loss from operations
-$32,470K
(-48.22%↓ Y/Y)
Unrealized gain on
marketable securities
-$364K
(-208.47%↓ Y/Y)
Total operating
expenses
$32,470K
(48.22%↑ Y/Y)
Research and development
$21,864K
(42.13%↑ Y/Y)
General and
administrative
$10,606K
(62.59%↑ Y/Y)
Buy us a coffee
Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc. (SION)